| Year |
Citation |
Score |
| 2019 |
Rajaram S, Roth MA, Malato J, VandenBerg S, Hann B, Atreya CE, Altschuler SJ, Wu LF. A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors. Scientific Data. 6: 253. PMID 31672976 DOI: 10.1038/S41597-019-0225-0 |
0.332 |
|
| 2019 |
Wang J, Merino DM, Light N, Murphy BL, Wang YD, Guo X, Hodges AP, Chau LQ, Liu KW, Dhall G, Asgharzadeh S, Kiehna EN, Shirey RJ, Janda KD, Taylor MD, ... ... VandenBerg SR, et al. Myc and loss of p53 cooperate to drive formation of choroid plexus carcinoma. Cancer Research. PMID 30885981 DOI: 10.1158/0008-5472.Can-18-2565 |
0.37 |
|
| 2019 |
Campbell MJ, Yau C, Bolen J, Vandenberg S, Hoyt C, Brown-Swigart L, Hirst G, Nanda R, Liu M, Asare S, van'tVeer L, Yee D, DeMichele A, Berry D, Esserman L, et al. Abstract CT003: Analysis of immune cell infiltrates as predictors of response to the checkpoint inhibitor pembrolizumab in the neoadjuvant I-SPY 2 TRIAL Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Ct003 |
0.324 |
|
| 2019 |
Atreya CE, Ruiz-Saenz A, Wang C, Pan B, Dreyer CA, Brunen D, Prahallad A, Spassov D, Steffen DJ, Hann BC, VandenBerg SR, Gutkind S, Moasser MM, Veer LJv', Coppe J. Abstract B023: A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF(V600E) colorectal tumors Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-B023 |
0.371 |
|
| 2018 |
Campbell M, Yau C, Borowsky A, Vandenberg S, Wolf D, Rimm D, Nanda R, Liu M, Brown-Swigart L, Hirst G, Asare S, Veer Lv, Yee D, DeMichele A, Berry D, et al. Abstract PD6-08: Analysis of immune infiltrates (assessed via multiplex fluorescence immunohistochemistry) and immune gene expression signatures as predictors of response to the checkpoint inhibitor pembrolizumab in the neoadjuvant I-SPY 2 trial Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd6-08 |
0.341 |
|
| 2016 |
Li J, Taich ZJ, Akers J, Vandenberg S, Chen CC. Abstract 4459: Altered signal transduction in Isocitrate Dehydrogenase (IDH) mutated glioblastomas and implication on precision medicine Cancer Research. 76: 4459-4459. DOI: 10.1158/1538-7445.Am2016-4459 |
0.327 |
|
| 2015 |
Jones KA, Gilder AS, Lam MS, Du N, Banki MA, Merati A, Pizzo DP, VandenBerg SR, Gonias SL. Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature. Neuro-Oncology. PMID 26420897 DOI: 10.1093/Neuonc/Nov243 |
0.752 |
|
| 2015 |
Kozono D, Li J, Nitta M, Sampetrean O, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon CH, ... ... VandenBerg SR, et al. Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression. Proceedings of the National Academy of Sciences of the United States of America. 112: E4055-64. PMID 26159421 DOI: 10.1073/Pnas.1501967112 |
0.325 |
|
| 2015 |
Wykosky J, Hu J, Gomez GG, Taylor T, Villa GR, Pizzo D, VandenBerg SR, Thorne AH, Chen CC, Mischel PS, Gonias SL, Cavenee WK, Furnari FB. A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma. Cancer Research. 75: 394-404. PMID 25432173 DOI: 10.1158/0008-5472.Can-14-2004 |
0.542 |
|
| 2015 |
Chen C, Kozono D, Li J, Nitta M, Sampetrean O, Ng K, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, ... ... VandenBerg SR, et al. Abstract PR02: Dynamic epigenetic regulation of glioblastoma tumorigenicity through a LSD1-MYC-OLIG2 axis Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-Pr02 |
0.347 |
|
| 2015 |
Kozono D, Li J, Nitta M, Sampetrean O, Ng K, Gonda D, Kushwaha D, Hiroko M, Harismendy O, Becher O, Kwon C, Ligon KL, Saya H, Carter BS, Pizzo D, ... Vandenberg S, et al. Abstract PR13: Epigenetic regulation of MYC drives dynamic transition between tumor initiating states in glioblastoma Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-Pr13 |
0.387 |
|
| 2015 |
Li J, Kozono D, Nitta M, Sampetrean O, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon C, ... ... VandenBerg SR, et al. Abstract 979: Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression Cancer Research. 75: 979-979. DOI: 10.1158/1538-7445.Am2015-979 |
0.386 |
|
| 2015 |
Li J, Taich Z, Goyal A, Gonda D, Akers J, Adhikari B, Patel K, Vandenberg S, Yan W, Bao Z, Carter B, Wang R, Mao Y, Chen C. EPIG-03EPIGENETIC SUPPRESSION OF EGFR SIGNALING IN G-CIMP + GLIOBLASTOMAS Neuro-Oncology. 17: v86.3-v86. DOI: 10.1093/Neuonc/Nov214.03 |
0.315 |
|
| 2015 |
Kozono D, Li J, Sampetrean O, Gonda D, Kushwaha D, Merzon D, Nitta M, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon C, ... ... Vandenberg S, et al. EPIG-02DYNAMIC EPIGENETIC MODULATION OF GLIOBLASTOMA TUMORIGENICITY BY INHIBITION OF LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1) Neuro-Oncology. 17: v86.2-v86. DOI: 10.1093/Neuonc/Nov214.02 |
0.356 |
|
| 2014 |
Hu J, Muller KA, Furnari FB, Cavenee WK, VandenBerg SR, Gonias SL. Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling. Oncogene. PMID 25347738 DOI: 10.1038/onc.2014.336 |
0.568 |
|
| 2014 |
Li J, Taich ZJ, Goyal A, Gonda D, Akers J, Adhikari B, Patel K, Vandenberg S, Yan W, Bao Z, Carter BS, Wang R, Mao Y, Jiang T, Chen CC. Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas. Oncotarget. 5: 7342-56. PMID 25277177 DOI: 10.18632/Oncotarget.2350 |
0.316 |
|
| 2014 |
Farid N, Almeida-Freitas DB, White NS, McDonald CR, Kuperman JM, Almutairi AA, Muller KA, VandenBerg SR, Kesari S, Dale AM. Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria). Journal of Neuro-Oncology. 120: 539-46. PMID 25135423 DOI: 10.1007/S11060-014-1583-2 |
0.329 |
|
| 2014 |
Hartman LL, Crawford JR, Makale MT, Milburn M, Joshi S, Salazar AM, Hasenauer B, VandenBerg SR, MacDonald TJ, Durden DL. Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors. Journal of Pediatric Hematology/Oncology. 36: 451-7. PMID 24309609 DOI: 10.1097/Mph.0000000000000047 |
0.315 |
|
| 2014 |
Wang J, Eberhart C, Ellison D, Vandenberg S, Wechsler-Reya R. PM-22 * GENETICALLY ENGINEERED MOUSE MODELS OF CHOROID PLEXUS TUMORS Neuro-Oncology. 16: v173-v173. DOI: 10.1093/Neuonc/Nou268.22 |
0.399 |
|
| 2014 |
Chen C, Kozono D, Li J, Nitta M, Sampetrean O, Gonda D, Kushwaha D, Vandenberg S, Ramakrishnan V, Zhu S, Furnari F, Matsui H, Harismendy O, Cavenee W, Mao Y, et al. CB-04 * EPIGENETIC REGULATION OF GLIOBLASTOMA TUMORIGENICITY: A HYBRID MODEL Neuro-Oncology. 16: v41-v41. DOI: 10.1093/Neuonc/Nou241.4 |
0.367 |
|
| 2013 |
Staudt ND, Jo M, Hu J, Bristow JM, Pizzo DP, Gaultier A, VandenBerg SR, Gonias SL. Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors. Cancer Research. 73: 3902-12. PMID 23633492 DOI: 10.1158/0008-5472.Can-12-4233 |
0.605 |
|
| 2013 |
Read RD, Fenton TR, Gomez GG, Wykosky J, Vandenberg SR, Babic I, Iwanami A, Yang H, Cavenee WK, Mischel PS, Furnari FB, Thomas JB. A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma. Plos Genetics. 9: e1003253. PMID 23459592 DOI: 10.1371/Journal.Pgen.1003253 |
0.361 |
|
| 2013 |
Stoletov K, Strnadel J, Zardouzian E, Momiyama M, Park FD, Kelber JA, Pizzo DP, Hoffman R, VandenBerg SR, Klemke RL. Role of connexins in metastatic breast cancer and melanoma brain colonization. Journal of Cell Science. 126: 904-13. PMID 23321642 DOI: 10.1242/Jcs.112748 |
0.323 |
|
| 2013 |
Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Vandenberg S, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/Neuonc/Not174 |
0.532 |
|
| 2012 |
Fenton TR, Nathanson D, Ponte de Albuquerque C, Kuga D, Iwanami A, Dang J, Yang H, Tanaka K, Oba-Shinjo SM, Uno M, Inda MM, Wykosky J, Bachoo RM, James CD, DePinho RA, ... Vandenberg SR, et al. Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240. Proceedings of the National Academy of Sciences of the United States of America. 109: 14164-9. PMID 22891331 DOI: 10.1073/Pnas.1211962109 |
0.356 |
|
| 2011 |
Cho J, Pastorino S, Zeng Q, Xu X, Johnson W, Vandenberg S, Verhaak R, Cherniack AD, Watanabe H, Dutt A, Kwon J, Chao YS, Onofrio RC, Chiang D, Yuza Y, et al. Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies. Cancer Research. 71: 7587-96. PMID 22001862 DOI: 10.1158/0008-5472.Can-11-0821 |
0.301 |
|
| 2011 |
Sugiarto S, Persson AI, Munoz EG, Waldhuber M, Lamagna C, Andor N, Hanecker P, Ayers-Ringler J, Phillips J, Siu J, Lim DA, Vandenberg S, Stallcup W, Berger MS, Bergers G, et al. Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell. 20: 328-40. PMID 21907924 DOI: 10.1016/J.Ccr.2011.08.011 |
0.35 |
|
| 2011 |
Hu J, Jo M, Cavenee WK, Furnari F, VandenBerg SR, Gonias SL. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 15984-9. PMID 21896743 DOI: 10.1073/Pnas.1113416108 |
0.619 |
|
| 2011 |
Khayal IS, Vandenberg SR, Smith KJ, Cloyd CP, Chang SM, Cha S, Nelson SJ, McKnight TR. MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas. Neuro-Oncology. 13: 1192-201. PMID 21865401 DOI: 10.1093/Neuonc/Nor122 |
0.309 |
|
| 2011 |
Zheng S, Houseman EA, Morrison Z, Wrensch MR, Patoka JS, Ramos C, Haas-Kogan DA, McBride S, Marsit CJ, Christensen BC, Nelson HH, Stokoe D, Wiemels JL, Chang SM, Prados MD, ... ... Vandenberg SR, et al. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. Neuro-Oncology. 13: 280-9. PMID 21339190 DOI: 10.1093/Neuonc/Noq190 |
0.322 |
|
| 2011 |
Otero JJ, Rowitch D, Vandenberg S. OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms. Journal of Neuro-Oncology. 104: 423-38. PMID 21193945 DOI: 10.1007/S11060-010-0509-X |
0.38 |
|
| 2011 |
Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, ... ... VandenBerg S, et al. The genetic landscape of the childhood cancer medulloblastoma. Science (New York, N.Y.). 331: 435-9. PMID 21163964 DOI: 10.1126/Science.1198056 |
0.328 |
|
| 2011 |
Inda MDM, Bonavia R, Vandenberg S, Cavenee W, Furnari F. Abstract 1129: Function of mutant EGFR in maintaining glioblastoma growth and heterogeneity Cancer Research. 71: 1129-1129. DOI: 10.1158/1538-7445.Am2011-1129 |
0.44 |
|
| 2010 |
Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, Auvergne R, Goldenberg DD, Vandenberg SR, Nguyen KN, Yakovenko S, Ayers-Ringler J, Nishiyama A, Stallcup WB, Berger MS, Bergers G, et al. Non-stem cell origin for oligodendroglioma. Cancer Cell. 18: 669-82. PMID 21156288 DOI: 10.1016/J.Ccr.2010.10.033 |
0.392 |
|
| 2010 |
Inda MM, Bonavia R, Mukasa A, Narita Y, Sah DW, Vandenberg S, Brennan C, Johns TG, Bachoo R, Hadwiger P, Tan P, Depinho RA, Cavenee W, Furnari F. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes & Development. 24: 1731-45. PMID 20713517 DOI: 10.1101/Gad.1890510 |
0.443 |
|
| 2010 |
Srinivasan R, Phillips JJ, Vandenberg SR, Polley MY, Bourne G, Au A, Pirzkall A, Cha S, Chang SM, Nelson SJ. Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM. Neuro-Oncology. 12: 1152-61. PMID 20647244 DOI: 10.1093/Neuonc/Noq075 |
0.339 |
|
| 2010 |
Swartling FJ, Grimmer MR, Hackett CS, Northcott PA, Fan QW, Goldenberg DD, Lau J, Masic S, Nguyen K, Yakovenko S, Zhe XN, Gilmer HC, Collins R, Nagaoka M, Phillips JJ, ... ... Vandenberg SR, et al. Pleiotropic role for MYCN in medulloblastoma. Genes & Development. 24: 1059-72. PMID 20478998 DOI: 10.1101/Gad.1907510 |
0.399 |
|
| 2010 |
Wu AH, Drees JC, Wang H, VandenBerg SR, Lal A, Henner WD, Pillai R. Gene expression profiles help identify the tissue of origin for metastatic brain cancers. Diagnostic Pathology. 5: 26. PMID 20420692 DOI: 10.1186/1746-1596-5-26 |
0.345 |
|
| 2010 |
Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, Greve JM, Soriano RH, Gilmour LL, Rivers CS, Modrusan Z, Nacu S, Guerrero S, Edgar KA, Wallin JJ, ... ... VandenBerg SR, et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell. 17: 362-75. PMID 20385361 DOI: 10.1016/J.Ccr.2009.12.049 |
0.353 |
|
| 2010 |
Hashizume R, Gupta N, Berger MS, Banerjee A, Prados MD, Ayers-Ringler J, James CD, VandenBerg SR. Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing. Neuro-Oncology. 12: 366-76. PMID 20308314 DOI: 10.1093/Neuonc/Nop033 |
0.389 |
|
| 2010 |
Park I, Larson PE, Zierhut ML, Hu S, Bok R, Ozawa T, Kurhanewicz J, Vigneron DB, Vandenberg SR, James CD, Nelson SJ. Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro-Oncology. 12: 133-44. PMID 20150380 DOI: 10.1093/Neuonc/Nop043 |
0.318 |
|
| 2010 |
Schiffman JD, Hodgson JG, VandenBerg SR, Flaherty P, Polley MY, Yu M, Fisher PG, Rowitch DH, Ford JM, Berger MS, Ji H, Gutmann DH, James CD. Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Research. 70: 512-9. PMID 20068183 DOI: 10.1158/0008-5472.Can-09-1851 |
0.344 |
|
| 2010 |
Inda M, Bonavia R, Sah DW, Vandenberg S, Brennan C, Johns TG, Hadwiger P, Tan P, Cavenee WK, Furnari FB. Abstract 3126: Tumor heterogeneity in glioblastoma is an active process driven by a mutant EGFR-induced paracrine circuit Cancer Research. 70: 3126-3126. DOI: 10.1158/1538-7445.Am10-3126 |
0.432 |
|
| 2009 |
Pirzkall A, McGue C, Saraswathy S, Cha S, Liu R, Vandenberg S, Lamborn KR, Berger MS, Chang SM, Nelson SJ. Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro-Oncology. 11: 842-52. PMID 19229057 DOI: 10.1215/15228517-2009-005 |
0.322 |
|
| 2009 |
Hodgson JG, Yeh RF, Ray A, Wang NJ, Smirnov I, Yu M, Hariono S, Silber J, Feiler HS, Gray JW, Spellman PT, Vandenberg SR, Berger MS, James CD. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. Neuro-Oncology. 11: 477-87. PMID 19139420 DOI: 10.1215/15228517-2008-113 |
0.367 |
|
| 2008 |
Striedinger K, VandenBerg SR, Baia GS, McDermott MW, Gutmann DH, Lal A. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Neoplasia (New York, N.Y.). 10: 1204-12. PMID 18953429 DOI: 10.1593/Neo.08642 |
0.386 |
|
| 2008 |
Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. Bmc Medicine. 6: 14. PMID 18577219 DOI: 10.1186/1741-7015-6-14 |
0.377 |
|
| 2008 |
Scheithauer BW, Fuller GN, VandenBerg SR. The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology. Brain Pathology (Zurich, Switzerland). 18: 307-16. PMID 18532929 DOI: 10.1111/J.1750-3639.2008.00179.X |
0.346 |
|
| 2008 |
Du R, Petritsch C, Lu K, Liu P, Haller A, Ganss R, Song H, Vandenberg S, Bergers G. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro-Oncology. 10: 254-64. PMID 18359864 DOI: 10.1215/15228517-2008-001 |
0.333 |
|
| 2008 |
Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegué E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 13: 206-20. PMID 18328425 DOI: 10.1016/J.Ccr.2008.01.034 |
0.35 |
|
| 2008 |
Baia GS, Dinca EB, Ozawa T, Kimura ET, McDermott MW, James CD, VandenBerg SR, Lal A. An orthotopic skull base model of malignant meningioma. Brain Pathology (Zurich, Switzerland). 18: 172-9. PMID 18093250 DOI: 10.1111/J.1750-3639.2007.00109.X |
0.374 |
|
| 2008 |
Scheithauer BW, Fuller GN, VandenBerg SR. The 2007 WHO classification of tumors of the nervous system: Controversies in surgical neuropathology (Brain Pathology (2008) 18, (307-316)) Brain Pathology. 18. DOI: 10.1111/J.1750-3639.2008.00219_1.X |
0.314 |
|
| 2007 |
Carvalho LH, Smirnov I, Baia GS, Modrusan Z, Smith JS, Jun P, Costello JF, McDermott MW, Vandenberg SR, Lal A. Molecular signatures define two main classes of meningiomas. Molecular Cancer. 6: 64. PMID 17937814 DOI: 10.1186/1476-4598-6-64 |
0.32 |
|
| 2007 |
Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro-Oncology. 9: 424-9. PMID 17622647 DOI: 10.1215/15228517-2007-023 |
0.361 |
|
| 2007 |
Wiencke JK, Zheng S, Jelluma N, Tihan T, Vandenberg S, Tamgüney T, Baumber R, Parsons R, Lamborn KR, Berger MS, Wrensch MR, Haas-Kogan DA, Stokoe D. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro-Oncology. 9: 271-9. PMID 17504928 DOI: 10.1215/15228517-2007-003 |
0.353 |
|
| 2006 |
Cadieux B, Ching TT, VandenBerg SR, Costello JF. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Research. 66: 8469-76. PMID 16951158 DOI: 10.1158/0008-5472.Can-06-1547 |
0.304 |
|
| 2006 |
Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S, Alvarez-Buylla A. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron. 51: 187-99. PMID 16846854 DOI: 10.1016/J.Neuron.2006.06.012 |
0.355 |
|
| 2006 |
Baia GS, Slocum AL, Hyer JD, Misra A, Sehati N, VandenBerg SR, Feuerstein BG, Deen DF, McDermott MW, Lal A. A genetic strategy to overcome the senescence of primary meningioma cell cultures. Journal of Neuro-Oncology. 78: 113-21. PMID 16554968 DOI: 10.1007/S11060-005-9076-Y |
0.357 |
|
| 2005 |
Entin-Meer M, Rephaeli A, Yang X, Nudelman A, VandenBerg SR, Haas-Kogan DA. Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas. Molecular Cancer Therapeutics. 4: 1952-61. PMID 16373710 DOI: 10.1158/1535-7163.Mct-05-0087 |
0.32 |
|
| 2005 |
Ozawa T, Britz GW, Kinder DH, Spence AM, VandenBerg S, Lamborn KR, Deen DF, Berger MS. Bromophenol blue staining of tumors in a rat glioma model. Neurosurgery. 57: 1041-7; discussion 1. PMID 16284574 DOI: 10.1227/01.Neu.0000180036.42193.F6 |
0.337 |
|
| 2005 |
Salasznyk RM, Westcott AM, Klees RF, Ward DF, Xiang Z, Vandenberg S, Bennett K, Plopper GE. Comparing the protein expression profiles of human mesenchymal stem cells and human osteoblasts using gene ontologies. Stem Cells and Development. 14: 354-66. PMID 16137224 DOI: 10.1089/Scd.2005.14.354 |
0.3 |
|
| 2004 |
Rola R, Raber J, Rizk A, Otsuka S, VandenBerg SR, Morhardt DR, Fike JR. Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Experimental Neurology. 188: 316-30. PMID 15246832 DOI: 10.1016/J.Expneurol.2004.05.005 |
0.301 |
|
| 2002 |
Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR. Immunophenotype of pleomorphic xanthoastrocytoma. The American Journal of Surgical Pathology. 26: 479-85. PMID 11914626 DOI: 10.1097/00000478-200204000-00010 |
0.304 |
|
| 2002 |
Hussaini IM, Carpenter JE, Redpath GT, Sando JJ, Shaffrey ME, Vandenberg SR. Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation. Neuro-Oncology. 4: 9-21. PMID 11772428 DOI: 10.1093/Neuonc/4.1.9 |
0.358 |
|
| 2001 |
Mandell JW, Gocan NC, Vandenberg SR. Mechanical trauma induces rapid astroglial activation of ERK/MAP kinase: Evidence for a paracrine signal. Glia. 34: 283-95. PMID 11360301 DOI: 10.1002/Glia.1062 |
0.309 |
|
| 2000 |
Hussaini IM, Karns LR, Vinton G, Carpenter JE, Redpath GT, Sando JJ, VandenBerg SR. Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cells. The Journal of Biological Chemistry. 275: 22348-54. PMID 10806212 DOI: 10.1074/Jbc.M003203200 |
0.374 |
|
| 1999 |
Hirano H, Lopes MB, Laws ER, Asakura T, Goto M, Carpenter JE, Karns LR, VandenBerg SR. Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. Neuro-Oncology. 1: 109-19. PMID 11550306 DOI: 10.1093/Neuonc/1.2.109 |
0.383 |
|
| 1999 |
Mandell JW, VandenBerg SR. ERK/MAP kinase is chronically activated in human reactive astrocytes. Neuroreport. 10: 3567-72. PMID 10619645 DOI: 10.1097/00001756-199911260-00019 |
0.304 |
|
| 1999 |
Hussaini IM, Brown MD, Weaver AM, Carpenter J, Karns LR, Vandenberg SR, Gonias SL. Stable antisense RNA expression neutralizes the activity of low-density lipoprotein receptor-related protein and promotes urokinase accumulation in the medium of an astrocytic tumor cell line. Antisense & Nucleic Acid Drug Development. 9: 183-90. PMID 10355824 DOI: 10.1089/Oli.1.1999.9.183 |
0.618 |
|
| 1999 |
Hussaini IM, Brown MD, Karns LR, Carpenter J, Redpath GT, Gonias SL, Vandenberg SR. Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes. Glia. 25: 71-84. PMID 9888299 DOI: 10.1002/(Sici)1098-1136(19990101)25:1<71::Aid-Glia7>3.0.Co;2-0 |
0.62 |
|
| 1998 |
Mandell JW, Hussaini IM, Zecevic M, Weber MJ, VandenBerg SR. In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. The American Journal of Pathology. 153: 1411-23. PMID 9811332 DOI: 10.1016/S0002-9440(10)65728-8 |
0.379 |
|
| 1997 |
Decaestecker C, Lopes BS, Gordower L, Camby I, Cras P, Martin JJ, Kiss R, VandenBerg SR, Salmon I. Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas. Journal of Neuropathology and Experimental Neurology. 56: 391-402. PMID 9100670 DOI: 10.1097/00005072-199704000-00008 |
0.327 |
|
| 1997 |
Brown MD, Banker GA, Hussaini IM, Gonias SL, VandenBerg SR. Low density lipoprotein receptor-related protein is expressed early and becomes restricted to a somatodendritic domain during neuronal differentiation in culture. Brain Research. 747: 313-7. PMID 9046007 DOI: 10.1016/S0006-8993(96)01321-2 |
0.537 |
|
| 1996 |
Lopes MB, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathologica. 91: 368-75. PMID 8928613 DOI: 10.1007/S004010050438 |
0.396 |
|
| 1996 |
Shaffrey ME, Lanzino G, Lopes MB, Hessler RB, Kassell NF, VandenBerg SR. Maturation of intracranial immature teratomas. Report of two cases. Journal of Neurosurgery. 85: 672-6. PMID 8814173 DOI: 10.3171/Jns.1996.85.4.0672 |
0.343 |
|
| 1996 |
Hussaini IM, LaMarre J, Lysiak JJ, Karns LR, VandenBerg SR, Gonias SL. Transcriptional regulation of LDL receptor-related protein by IFN-gamma and the antagonistic activity of TGF-beta(1) in the RAW 264.7 macrophage-like cell line. Journal of Leukocyte Biology. 59: 733-9. PMID 8656060 DOI: 10.1002/Jlb.59.5.733 |
0.535 |
|
| 1996 |
Hussaini IM, Lopes MB, Musante DB, Karns LR, VandenBerg SR. EXPRESSION OF IGF-1 AND IGF-1R IN REACTIVE ASTROCYTES AND ASTROCYTIC TUMORS Journal of Neuropathology and Experimental Neurology. 55: 606. DOI: 10.1097/00005072-199605000-00020 |
0.305 |
|
| 1995 |
Hirose T, Scheithauer BW, Lopes MB, Gerber HA, Altermatt HJ, Hukee MJ, VandenBerg SR, Charlesworth JC. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta Neuropathologica. 90: 387-99. PMID 8546029 DOI: 10.1007/Bf00315012 |
0.359 |
|
| 1994 |
Lopes MB, Bogaev CA, Gonias SL, VandenBerg SR. Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells. Febs Letters. 338: 301-5. PMID 8307199 DOI: 10.1016/0014-5793(94)80288-2 |
0.55 |
|
| 1994 |
Turner JS, Redpath GT, Humphries JE, Gonias SL, Vandenberg SR. Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells. The Biochemical Journal. 297: 175-9. PMID 8280096 DOI: 10.1042/Bj2970175 |
0.541 |
|
| 1994 |
Hirose T, Scheithauer BW, Lopes MB, VandenBerg SR. Dysembryoplastic neuroeptihelial tumor (DNT): an immunohistochemical and ultrastructural study. Journal of Neuropathology and Experimental Neurology. 53: 184-95. PMID 8120540 DOI: 10.1097/00005072-199403000-00010 |
0.358 |
|
| 1993 |
Lopes MB, Gonzalez-Fernandez F, Scheithauer BW, VandenBerg SR. Differential expression of retinal proteins in a pineal parenchymal tumor. Journal of Neuropathology and Experimental Neurology. 52: 516-24. PMID 8360704 DOI: 10.1097/00005072-199309000-00010 |
0.353 |
|
| 1993 |
Altermatt HJ, Lopes MB, Scheithauer BW, VandenBerg SR. THE IMMUNOCHEMISTRY OF SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA) IN TUBEROUS SCLEROSIS (TS) Journal of Neuropathology and Experimental Neurology. 52: 326. DOI: 10.1097/00005072-199305000-00265 |
0.311 |
|
| 1992 |
Hessler RB, Lopes MB, Frankfurter A, Reidy J, VandenBerg SR. Cytoskeletal immunohistochemistry of central neurocytomas. The American Journal of Surgical Pathology. 16: 1031-8. PMID 1471723 DOI: 10.1097/00000478-199211000-00001 |
0.361 |
|
| 1992 |
VandenBerg SR. Current diagnostic concepts of astrocytic tumors. Journal of Neuropathology and Experimental Neurology. 51: 644-57. PMID 1362439 DOI: 10.1097/00005072-199211000-00008 |
0.312 |
|
| 1991 |
Humphries J, Hall S, VandenBerg S, Gonias S. Streptokinase-plasmin complex binds to plasminogen receptors on rat hepatocytes and human endothelium Fibrinolysis. 5: 171-176. DOI: 10.1016/0268-9499(91)90019-Z |
0.542 |
|
| 1990 |
Hall SW, VandenBerg SR, Gonias SL. Plasminogen carbohydrate side chains in receptor binding and enzyme activation: a study of C6 glioma cells and primary cultures of rat hepatocytes. Journal of Cellular Biochemistry. 43: 213-27. PMID 1696276 DOI: 10.1002/Jcb.240430303 |
0.565 |
|
| 1990 |
Keohane ME, Hall SW, VandenBerg SR, Gonias SL. Secretion of alpha 2-macroglobulin, alpha 2-antiplasmin, and plasminogen activator inhibitor-1 by glioblastoma multiforme in primary organ culture. Journal of Neurosurgery. 73: 234-41. PMID 1694891 DOI: 10.3171/Jns.1990.73.2.0234 |
0.527 |
|
| 1989 |
VandenBerg SR, Gonias SL. Covalent complexes of albumin with serotonin, ketanserin and lysergic acid antagonize the activity of serotonin in human platelets. Life Sciences. 44: 1777-85. PMID 2733551 DOI: 10.1016/0024-3205(89)90565-1 |
0.489 |
|
| 1989 |
VandenBerg SR, Britt SG, Redpath GT, Gonias SL. 5-Hydroxytryptamine2 (5-HT2) structure-function relationships of the nitro and amino phenylpiperazines on intact human platelets. Biochemical Pharmacology. 38: 4237-44. PMID 2597195 DOI: 10.1016/0006-2952(89)90521-2 |
0.514 |
|
| 1989 |
Klein P, Haley EC, Wooten GF, VandenBerg SR. Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases. Archives of Neurology. 46: 1149-52. PMID 2552969 DOI: 10.1001/Archneur.1989.00520460145030 |
0.323 |
|
| 1989 |
Hall SW, VandenBerg SR, Gonias SL. Expression of plasminogen receptors on C6 glioma cells. Brain Research. 495: 373-6. PMID 2548675 DOI: 10.1016/0006-8993(89)90231-X |
0.57 |
|
| 1989 |
Gonias SL, Braud LL, Geary WA, VandenBerg SR. Plasminogen binding to rat hepatocytes in primary culture and to thin slices of rat liver. Blood. 74: 729-36. PMID 2546631 DOI: 10.1182/Blood.V74.2.729.Bloodjournal742729 |
0.527 |
|
| 1987 |
VandenBerg SR, May EE, Rubinstein LJ, Herman MM, Perentes E, Vinores SA, Collins VP, Park TS. Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential ("desmoplastic infantile gangliogliomas"). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis. Journal of Neurosurgery. 66: 58-71. PMID 3097276 DOI: 10.3171/Jns.1987.66.1.0058 |
0.379 |
|
| 1987 |
Vandenberg SR, Herman MM, Rubinstein LJ. Embryonal central neuroepithelial tumors: current concepts and future challenges. Cancer Metastasis Reviews. 5: 343-65. PMID 2882864 DOI: 10.1007/Bf00055377 |
0.386 |
|
| 1984 |
Weaver D, Vandenberg S, Park TS, Jane JA. Selective peripancreatic sarcoma metastases from primary gliosarcoma. Case report. Journal of Neurosurgery. 61: 599-601. PMID 6747700 DOI: 10.3171/Jns.1984.61.3.0599 |
0.323 |
|
| 1982 |
Ramsay PB, VandenBerg SR, Eng LF, Herman MM, Rubinstein LJ. Immunologic recognition of cell surface antigens in normal mouse neural tissues and in neuroepithelial cells of the OTT-6050 mouse teratoma. A radiometric, gel electrophoretic and morphologic (immunofluorescence and immunoperoxidase) study. Acta Neuropathologica. 56: 214-24. PMID 7200313 DOI: 10.1007/Bf00690638 |
0.318 |
|
| 1981 |
DeArmond SJ, VandenBerg SR, Herman MM. Neural differentiation in the OTT-6050 mouse teratoma: effects of intracerebral environment on the neural differentiation of embryoid bodies. Virchows Archiv. a, Pathological Anatomy and Histology. 393: 39-52. PMID 7347442 DOI: 10.1007/Bf00430869 |
0.345 |
|
| 1981 |
VandenBerg SR, Hess JR, Herman MM, DeArmond SJ, Halks-Miller M, Rubinstein LJ. Neural differentiation in the OTT-6050 mouse teratoma. Production of a tumor fraction showing melanogenesis in neuroepithelial cells after centrifugal elutriation. Virchows Archiv. a, Pathological Anatomy and Histology. 392: 295-308. PMID 7269229 DOI: 10.1007/Bf02155667 |
0.36 |
|
| 1981 |
VandenBerg SR, Chatel M, Griffiths OM, DeArmond SJ, Pappas C, Herman MM. Neural differentiation in the OTT-6050 mouse teratoma. Production of a tumor fraction restricted to stem cells and neural cells after centrifugal elutriation. Virchows Archiv. a, Pathological Anatomy and Histology. 392: 281-94. PMID 7269228 DOI: 10.1007/Bf02155666 |
0.37 |
|
| 1981 |
Erdelyi E, VandenBerg SR, Raese J, Barchas JD, Rubinstein LJ, Herman MM. Neural differentiation in the OTT-6050 mouse teratoma: enzymatic and immunofluorescence characterization of a tumor fraction showing melanogenesis in neuroepithelial cells. Virchows Archiv. a, Pathological Anatomy and Histology. 393: 27-37. PMID 6126948 DOI: 10.1007/Bf00430868 |
0.376 |
|
| 1976 |
Wada HG, VandenBerg SR, Sussman HH, Grove WE, Herman MM. Characterization of two different alkaline phosphatases in mouse teratoma: partial purification, electrophoretic, and histochemical studies. Cell. 9: 37-44. PMID 987856 DOI: 10.1016/0092-8674(76)90050-7 |
0.308 |
|
| 1976 |
Orenberg EK, Vandenberg SR, Barchas JD, Herman MM. Neurochemical studies in a mouse teratoma with neuroepithelial differentiation. Presence of cyclic AMP, serotonin and enzymes of the serotonergic, adrenergic and cholinergic systems. Brain Research. 101: 273-81. PMID 1140 DOI: 10.1016/0006-8993(76)90268-7 |
0.309 |
|
| 1975 |
Spence AM, Vandenberg SR, Herman MM. Intracisternal A-particles in transplantable murine teratomas. Beitrã¤Ge Zur Pathologie. 155: 428-34. PMID 1180813 DOI: 10.1016/S0005-8165(75)80105-3 |
0.301 |
|
| Show low-probability matches. |